These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 8139174)
1. [The choice of the optimal regimen for apheresis of the low-density lipoproteins in patients with familial hypercholesterolemia by using mathematical modelling]. Iarovaia EB; Rostapshova TV; Susekov AV; Kukharchuk VV Kardiologiia; 1993; 33(10):50-4, 6. PubMed ID: 8139174 [TBL] [Abstract][Full Text] [Related]
2. Effects of LDL apheresis on restenosis after angioplasty. Kanemitsu S; Tekekoshi N; Murakami E Chem Phys Lipids; 1994 Jan; 67-68():339-43. PubMed ID: 8187232 [TBL] [Abstract][Full Text] [Related]
3. Analysis of the long-term efficacy and selectivity of immunoadsorption columns for low density lipoprotein apheresis. Jovin IS; Taborski U; Müller-Berghaus G ASAIO J; 2000; 46(3):298-300. PubMed ID: 10826740 [TBL] [Abstract][Full Text] [Related]
4. One year experience with a low density lipoprotein apheresis system. Durst R; Rund D; Schurr D; Eliav O; Ben-Yehuda D; Shpizen S; Ben-Avi L; Schaap T; Pelz I; Leitersdorf E Isr Med Assoc J; 2002 Sep; 4(9):677-80. PubMed ID: 12440228 [TBL] [Abstract][Full Text] [Related]
5. Direct adsorption of low-density lipoprotein and lipoprotein(a) from whole blood: results of the first clinical long-term multicenter study using DALI apheresis. Bosch T; Lennertz A; Schenzle D; Dräger J; J Clin Apher; 2002; 17(4):161-9. PubMed ID: 12494408 [TBL] [Abstract][Full Text] [Related]
6. Effect of low-density lipoprotein apheresis on plasma levels of apolipoprotein e4. Moriarty PM; Luyendyk JP; Gibson CA; Backes JM Am J Cardiol; 2010 Jun; 105(11):1585-7. PubMed ID: 20494666 [TBL] [Abstract][Full Text] [Related]
7. The first results demonstrating efficiency and safety of a double-column whole blood method of LDL-apheresis. Hequet O; Le QH; Rigal D; Mekhloufi F; Jaeger S; Sassolas A; Groisne L; Moulin P Transfus Apher Sci; 2010 Feb; 42(1):3-10. PubMed ID: 19932056 [TBL] [Abstract][Full Text] [Related]
8. Low-density lipoprotein apheresis using the Liposorber dextran sulfate cellulose system for patients with hypercholesterolemia refractory to medical therapy. Gordon BR; Saal SD J Clin Apher; 1996; 11(3):128-31. PubMed ID: 8915816 [TBL] [Abstract][Full Text] [Related]
9. Comparative evaluation of a heparin-citrate anticoagulation for LDL-apheresis in two primary apheresis systems. Handschel D; Etienne Janssens M; Gericke M; De Reys S; Borberg H J Clin Apher; 2017 Oct; 32(5):319-328. PubMed ID: 27676234 [TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of DALI LDL-apheresis at high blood flow rates: a prospective multicenter study. Wendler T; Schilling R; Lennertz A; Sodemann K; Kleophas W; Messner H; Riechers G; Wagner J; Keller C; Bosch T J Clin Apher; 2003; 18(4):157-66. PubMed ID: 14699591 [TBL] [Abstract][Full Text] [Related]
11. Long-term therapeutic efficacy of lipoprotein apheresis on circulating oxidative stress parameters--A comparison of two different apheresis techniques. Kopprasch S; Bornstein SR; Bergmann S; Graessler J; Julius U Atheroscler Suppl; 2015 May; 18():80-4. PubMed ID: 25936309 [TBL] [Abstract][Full Text] [Related]
12. Acute changes in plasma levels of hepatocyte growth factor during low-density lipoprotein apheresis. Kojima S; Shida M; Tanaka K; Takano H; Yokoyama H; Kuramochi M Ther Apher; 2001 Feb; 5(1):2-6. PubMed ID: 11258604 [TBL] [Abstract][Full Text] [Related]
14. [Changes in serum lipids and lipoproteins in 3 cases of heterozygous familial hypercholesterolemia treated by LDL apheresis on dextran sulfate-cellulose columns]. Delplanque B; Emmerich J; Norol F; Jourdan D; Duedari N; Jacotot B Ann Med Interne (Paris); 1988; 139 Suppl 1():80-2. PubMed ID: 2470282 [TBL] [Abstract][Full Text] [Related]
15. Optimization of therapeutic procedure during LDL-apheresis - verification of the computerized model in clinical practice. Masin V; Blaha M; Stransky P; Blaha V; Cermanova M; Maly R; Zajic J Transfus Apher Sci; 2007 Feb; 36(1):39-45. PubMed ID: 17292673 [TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of a new whole-blood low-density lipoprotein apheresis system (Liposorber D) in severe hypercholesterolemia. Otto C; Kern P; Bambauer R; Kallert S; Schwandt P; Parhofer KG Artif Organs; 2003 Dec; 27(12):1116-22. PubMed ID: 14678426 [TBL] [Abstract][Full Text] [Related]
17. Low-density lipoprotein apheresis using the Liposorber system: features of the system and clinical benefits. Yamamoto T; Yamashita T Ther Apher; 1998 Feb; 2(1):25-30. PubMed ID: 10227785 [TBL] [Abstract][Full Text] [Related]
18. Comparison of different low density lipoprotein apheresis machines on brain natriuretic Peptide levels in patients with familial hypercholesterolemia. Moriarty P; Sosland R; Gibson C; Belmont J Ther Apher Dial; 2010 Feb; 14(1):74-8. PubMed ID: 20438521 [TBL] [Abstract][Full Text] [Related]
19. Low density lipoprotein (LDL) apheresis is currently recognized as a reliable tool for removal of LDL cholesterol directly from blood in patients with severe hypercholesterolemia. Agishi T Artif Organs; 2000 Feb; 24(2):165-6. PubMed ID: 10718772 [No Abstract] [Full Text] [Related]
20. Long-term effect of low-density lipoprotein apheresis in a patient with heterozygous familial hypercholesterolemia: follow-up study using coronary angiography. Saku K; Takeda Y; Jimi S; Okabe M; Shirai K; Nii T; Naito S; Arakawa K J Cardiol; 1998 Apr; 31(4):239-45. PubMed ID: 9594373 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]